Monoclonal Antibodies
PE Rabbit anti-Human Siglec-7/CD328 Monoclonal Antibody for FC - Q9Y286
Item Number : CM0006162
Price varies based on specs and customizations
- Application
- FC
- Cross Reactivity
- Human
- Protein Weight
- 51kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | PE Rabbit anti-Human Siglec-7/CD328 mAb |
| Remarks/Alias | p75; QA79; AIRM1; CD328; AIRM-1; CDw328; D-siglec; SIGLEC-7; SIGLECP2; SIGLEC19P; p75/AIRM1 |
| Species | Human |
| GeneID (human) | 27036 |
| GeneID | 27036 |
| Immunogen | Recombinant protein|Recombinant fusion protein containing a sequence corresponding to amino acids 18-144 of human Siglec-7/CD328 (NP_055200.1). |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | FC |
| Cross Reactivity | Human |
| SWISS | Q9Y286 |
| Protein Weight | 51kDa |
| Shipping | Ice bag |
Biological Background: Siglec-7 Function and Localization
- Sialic acid-binding Ig-like lectin 7 (Siglec-7), also known as CD328, AIRM-1, p75, and D-siglec, is encoded by the SIGLEC7 gene. It is a single-pass type I membrane protein belonging to the immunoglobulin superfamily.
- Functions as a putative adhesion molecule that mediates sialic-acid dependent binding to cells, with preference for α-2,3- and α-2,6-linked sialic acids and disialogangliosides. The sialic acid recognition site may be masked by cis interactions on the same cell surface.
- Acts as an inhibitory receptor in the immune response: upon ligand engagement, it undergoes tyrosine phosphorylation and recruits cytoplasmic phosphatases (e.g., SHP-1, SHP-2) via SH2 domains, leading to dephosphorylation of signaling molecules and attenuation of immune cell activation.
- Mediates inhibition of natural killer (NK) cell cytotoxicity, playing a critical role in regulating NK cell function and innate immunity.
- Involved in hematopoiesis; has been shown to inhibit differentiation of CD34+ cell precursors toward the myelomonocytic lineage and suppress proliferation of leukemic myeloid cells in vitro.
- Predominantly expressed on resting and activated NK cells, with lower levels on granulocytes and monocytes. High expression is observed in placenta, liver, lung, spleen, and peripheral blood leukocytes.
- Post-translational modifications include glycosylation and phosphorylation. Contains a signal peptide, an extracellular region with two Ig-like domains (one V-set, one C2-set), a transmembrane helix, and a cytoplasmic tail with ITIM and ITIM-like motifs.
Experimental Guidance and Technical Tips
- Since the immunogen corresponds to the extracellular domain (aa 18-144), the antibody likely recognizes an epitope in the N-terminal region, suitable for detecting native surface Siglec-7.
- This PE-conjugated antibody is intended for direct flow cytometry; optimal working dilution should be determined experimentally by titration in the relevant cell system (e.g., human PBMCs or NK cell lines).
- Consider including appropriate isotype controls and Fc receptor blocking to minimize non-specific binding.
- For combined multicolor flow cytometry panels, verify that the PE conjugate is compatible with other fluorophores and compensate appropriately.
CamelBio: Your One-Stop Sourcing Bridge
As a dedicated IVD raw material partner, CamelBio offers a streamlined sourcing experience for diagnostic developers and researchers. This anti-Siglec-7 antibody serves researchers in immunology and immuno-oncology, supporting studies on NK cell regulation and immune checkpoints. CamelBio provides validated antibody pairs, bulk monoclonal and polyclonal antibodies, and ancillary reagents, along with customized sourcing for rare targets.
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!